$10.64
0.57% yesterday
Nasdaq, May 20, 10:06 pm CET
ISIN
US53216B1044
Symbol
LFMD

LifeMD Stock price

$10.64
+5.25 97.22% 1M
+5.22 96.31% 6M
+5.69 114.95% YTD
+2.74 34.68% 1Y
+8.59 419.02% 3Y
+9.01 554.65% 5Y
+10.04 1,673.33% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.06 0.57%
ISIN
US53216B1044
Symbol
LFMD
Industry

Key metrics

Market capitalization $483.56m
Enterprise Value $476.21m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 34.16
EV/Sales (TTM) EV/Sales 2.03
P/S ratio (TTM) P/S ratio 2.07
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 43.07%
Revenue (TTM) Revenue $234.01m
EBIT (operating result TTM) EBIT $-7.43m
Free Cash Flow (TTM) Free Cash Flow $13.94m
Cash position $34.39m
EPS (TTM) EPS $-0.33
P/E forward negative
P/S forward 1.79
EV/Sales forward 1.76
Short interest 14.83%
Show more

Is LifeMD a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

LifeMD Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a LifeMD forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a LifeMD forecast:

Buy
89%
Hold
11%

Financial data from LifeMD

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
234 234
43% 43%
100%
- Direct Costs 40 40
45% 45%
17%
194 194
43% 43%
83%
- Selling and Administrative Expenses 182 182
30% 30%
78%
- Research and Development Expense 10 10
45% 45%
4%
2.62 2.62
125% 125%
1%
- Depreciation and Amortization 10 10
37% 37%
4%
EBIT (Operating Income) EBIT -7.43 -7.43
58% 58%
-3%
Net Profit -11 -11
54% 54%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about LifeMD directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeMD Stock News

Neutral
GlobeNewsWire
8 days ago
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May:
Neutral
Seeking Alpha
14 days ago
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.
Neutral
GlobeNewsWire
14 days ago
Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70% Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period Telehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago period GAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPS Raising...
More LifeMD News

Company Profile

LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.

Head office United States
CEO Justin Schreiber
Employees 336
Founded 1987
Website www.lifemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today